ArticleScientific reports2026
The G protein-coupled estrogen receptor in the nucleus accumbens mediates the estrogen-induced increase in cataplexy-like behavior.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Estrogen functions not only as a female reproductive hormone but also as a psychological agent in the brains of both sexes. Here, we examined the potential effect of estrogen on cataplexy attacks, which are triggered by positive emotions in narcoleptic humans and animals. In orexin neuron-ablated mice, an animal model of narcolepsy, the number of cataplexy-like behaviors increased with estrogen administration and decreased with tamoxifen, an estrogen receptor (ER) modulator, in both sexes. The increase in cataplexy-like behaviors caused by estrogen in ovariectomized female mice indicated its action outside reproductive organs. In female mice, the estrous cycle influenced the frequency of cataplexy-like behaviors, with the highest count during estrus, when blood estrogen levels peak. In a pharmacological study with male mice, a G protein-coupled estrogen receptor (GPER) antagonist reduced the frequency of cataplexy-like behaviors, while a GPER agonist increased it. Conversely, neither an ER alpha agonist nor an ER beta agonist showed any effect. The GPER agonist activated neurons in the nucleus accumbens (NAc). Finally, microinjection of a GPER agonist into the NAc increased the occurrence of cataplexy-like behaviors. Together, these results demonstrate that GPER in the NAc mediates the psychological effects of estrogen on cataplexy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.